Document is current
Any future updates will be listed below
-
Authors
de Boer, Mathijs https://orcid.org/0009-0004-6415-7194
Kos, Tessa M.
Fick, Tim
van Doormaal, Jesse A. M.
Colombo, Elisa
Kuijf, Hugo J.
Robe, Pierre A. J. T.
Regli, Luca P.
Bartels, Lambertus W.
van Doormaal, Tristan P. C.
-
Funding
Funding for this research was provided by:
Hanarth Fonds (MISTICAL)
- License Information
-
More Information
Article History
Received: 15 August 2023
Accepted: 22 January 2024
First Online: 20 February 2024
Declarations
:
: The anonymized data from two previous studies were partially reused in this study [, ]. Both datasets underwent the necessary ethical review processes as per their respective studies. Additional anonymous testing data was gathered under ethical approval; waiver of METC NedMec under application 22/845 in center A and KEK approval nr PB_2017_00093/NCT01628406 in center B.
: This work used retroactively gathered data under ethical approval; waiver of METC NedMec under application 22/845 in center A and KEK approval nr PB_2017_00093/NCT01628406 in center B.
: No identifiable information is included in this manuscript.
: Tristan van Doormaal is a co-founder and CMO of Augmedit B.V. which commercializes an augmented reality platform for neurosurgical applications. The research of Jesse van Doormaal is funded by Augmedit B.V.
